Key Points
- Heartflow CEO John C.M. Farquhar sold 22,562 shares on May 11 at an average price of $29.12, totaling about $657,005. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
- After the transaction, Farquhar still owned 519,397 shares valued at roughly $15.1 million, and the sale represented a 4.16% decrease in his position. He has also made several other recent share sales this spring.
- Heartflow stock rose 6.1% and opened at $31.20, while analysts remain generally positive with a Moderate Buy consensus and an average target price of $37.67. Institutional investors have also been increasing or initiating positions in the company.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John C.M. Farquhar sold 22,562 shares of the firm's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $29.12, for a total transaction of $657,005.44. Following the completion of the sale, the chief executive officer owned 519,397 shares of the company's stock, valued at $15,124,840.64. This trade represents a 4.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $26.72, for a total transaction of $602,856.64.
- On Wednesday, March 18th, John C.M. Farquhar sold 9,725 shares of Heartflow stock. The stock was sold at an average price of $25.00, for a total transaction of $243,125.00.
- On Tuesday, March 10th, John C.M. Farquhar sold 12,837 shares of Heartflow stock. The stock was sold at an average price of $22.66, for a total transaction of $290,886.42.
Heartflow Stock Up 6.1%
Shares of NASDAQ HTFL opened at $31.20 on Thursday. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $41.22. The firm has a 50-day moving average price of $27.02 and a 200 day moving average price of $28.91. The stock has a market capitalization of $2.69 billion and a price-to-earnings ratio of -15.68.
Institutional Investors Weigh In On Heartflow
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Sei Investments Co. grew its holdings in shares of Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company's stock worth $1,631,000 after buying an additional 51,895 shares in the last quarter. Walleye Capital LLC purchased a new stake in shares of Heartflow during the first quarter worth about $474,000. Bessemer Group Inc. purchased a new stake in shares of Heartflow during the first quarter worth about $126,000. Bank of New York Mellon Corp grew its holdings in shares of Heartflow by 25.5% during the first quarter. Bank of New York Mellon Corp now owns 61,048 shares of the company's stock worth $1,485,000 after buying an additional 12,395 shares in the last quarter. Finally, Staley Capital Advisers Inc. grew its holdings in Heartflow by 100.0% in the first quarter. Staley Capital Advisers Inc. now owns 14,000 shares of the company's stock valued at $341,000 after purchasing an additional 7,000 shares during the period.
Analyst Upgrades and Downgrades
HTFL has been the subject of several recent analyst reports. JPMorgan Chase & Co. reduced their price objective on shares of Heartflow from $40.00 to $35.00 and set an "overweight" rating for the company in a research note on Thursday, March 19th. William Blair initiated coverage on shares of Heartflow in a research note on Monday, May 4th. They issued an "outperform" rating for the company. Wells Fargo & Company reduced their price objective on shares of Heartflow from $38.00 to $35.00 and set an "overweight" rating for the company in a research note on Thursday, March 19th. Finally, Canaccord Genuity Group raised their price objective on shares of Heartflow from $40.00 to $43.00 and gave the company a "buy" rating in a research note on Thursday, March 19th. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Heartflow has a consensus rating of "Moderate Buy" and an average target price of $37.67.
View Our Latest Research Report on HTFL
About Heartflow
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
